PNC Financial Services Group’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$161 Sell
124
-113
-48% -$164 ﹤0.01% 5118
2026
Q1
$344 Buy
237
+232
+4,640% +$368 ﹤0.01% 4981
2025
Q4
$7 Hold
5
– – ﹤0.01% 5145
2025
Q3
$14 Buy
+5
New +$18 ﹤0.01% 5066
2022
Q3
– Sell
-981
Closed -$3K – 4608
2022
Q2
$3K Hold
981
– – ﹤0.01% 4136
2022
Q1
$3K Hold
981
– – ﹤0.01% 4130
2021
Q4
$4K Hold
981
– – ﹤0.01% 4035
2021
Q3
$6K Hold
981
– – ﹤0.01% 3898
2021
Q2
$16K Hold
981
– – ﹤0.01% 3561
2021
Q1
$12K Sell
981
-48
-5% -$736 ﹤0.01% 3597
2020
Q4
$11K Hold
1,029
– – ﹤0.01% 3544
2020
Q3
$5K Hold
1,029
– – ﹤0.01% 3681
2020
Q2
$2K Buy
+1,029
New +$2.11K ﹤0.01% 3793

Other funds holding STIM

PNC Financial Services Group's STIM Position: Q2 2026 in Review

PNC Financial Services Group reduced its Neuronetics (STIM) stake by 48% in Q2 2026, selling an estimated $164 and leaving 124 shares worth $161. The position accounts for ﹤0.01% of the portfolio, ranked #5118.

PNC Financial Services Group first reported a position in STIM in Q2 2020 and has held it in 13 quarters since. The position peaked at $16K in Q2 2021. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • PNC Financial Services Group held 124 shares of Neuronetics worth $161 as of Q2 2026.
  • PNC Financial Services Group sold 113 Neuronetics shares in Q2 2026, an estimated $164.
  • Neuronetics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #5118 holding.
  • PNC Financial Services Group first reported a position in Neuronetics in Q2 2020 and has held it in 13 quarters since.
  • PNC Financial Services Group's Neuronetics position peaked at $16K in Q2 2021.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.